Novel model predicts diastolic cardiac dysfunction in type 2 diabetes

References

• Formiga A, Camafort M, Carrasco Sánchez FJ. Heart failure and diabetes: the confrontation of two major epidemics of the 21st century - ScienceDirect. Rev Clin Esp (Barc). 2020;220(2):135–138.
   PubMed Web of Science ®Google Scholar
• Rubler S, Dlugash J, Yuceoglu YZ, et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30(6):595–602.
   PubMed Web of Science ®Google Scholar
• Seferović Mitrović JP, Seferović PM, Vujisić Tešić B, et al. Predictors of diabetic cardiomyopathy in asymptomatic patients with type 2 diabetes. Int J Cardiol. 2012;156(2):219–221.
   PubMed Web of Science ®Google Scholar
• Dandamudi S, Slusser J, Mahoney DW, et al. The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota. J Card Fail. 2014;20(5):304–309.
   PubMed Web of Science ®Google Scholar
• Westermeier F, Jaime A, Riquelme M, et al. New molecular insights of insulin in diabetic cardiomyopathy. Front Physiol. 2016;7:125.
   PubMed Web of Science ®Google Scholar
• Kotturu S, Uddandrao V, Ghosh S, et al. Bioactive compounds in diabetic cardiomyopathy: current approaches and potential diagnostic and therapeutic targets. Cardiovasc Hematol Agents Med Chem. 2021;19(2):118–130.
   PubMedGoogle Scholar
• Mohan M, Dihoum A, Mordi IR, et al. Left ventricular hypertrophy in diabetic cardiomyopathy: a target for intervention. Front Cardiovasc Med. 2021;8:746382.
   PubMed Web of Science ®Google Scholar
• From AM, Scott CG, Chen HH. The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction: a population-based study. J Am Coll Cardiol. 2010;55(4):300–305.
   PubMed Web of Science ®Google Scholar
• Mishra PK, Wei Y, Sundar NS, et al. Diabetic cardiomyopathy: an immunometabolic perspective. Front Endocrinol. 2017;8:72.
   PubMedGoogle Scholar
• Hao M, Deng J, Huang X, et al. Metabonomic characteristics of myocardial diastolic dysfunction in type 2 diabetic cardiomyopathy patients. Front Physiol. 2022;13:863347.
   PubMed Web of Science ®Google Scholar
• Jin JP. Epidemiology, pathophysiology, diagnosis and treatment of heart failure in diabetes. Diabet Metab J. 2021;45(2):146–157.
   PubMed Web of Science ®Google Scholar
• Cefalu WT, Berg GE, Saraco M, et al. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13-S28.
   Google Scholar
• Stevens LA, Claybon MA, Schmid CH, et al. Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int. 2011;79(5):555–562.
   PubMed Web of Science ®Google Scholar
• Nishimura RA, Borlaug BA. Diastology for the clinician. J Cardiol. 2019;73(6):445–452.
   PubMed Web of Science ®Google Scholar
• Groenwold R, White IR, Donders A, et al. Missing covariate data in clinical research: when and when not to use the missing-indicator method for analysis. CMAJ. 2012;184(11):1265–1269.
   PubMed Web of Science ®Google Scholar
• White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Statist Med. 2011;30(4):377–399.
   PubMed Web of Science ®Google Scholar
• Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1–22.
   PubMed Web of Science ®Google Scholar
• Sauerbrei W, Royston P, Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Statist Med. 2007;26(30):5512–5528.
   PubMed Web of Science ®Google Scholar
• Kidd AC, Mcgettrick M, Tsim S, et al. Survival prediction in mesothelioma using a scalable Lasso regression model: instructions for use and initial performance using clinical predictors. BMJ Open Respir Res. 2018;5(1):e000240.
   PubMed Web of Science ®Google Scholar
• Barnard GA. Two further applications of a model for binary regression. Biometrika. 1958;45(3/4):562–565.
   Web of Science ®Google Scholar
• Kramer AA, Zimmerman JE. Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited. Crit Care Med. 2007;35(9):2052–2056.
   PubMed Web of Science ®Google Scholar
• Vickers AJ, Cronin AM, Elkin EB, et al. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak. 2008;8(1):53.
   PubMed Web of Science ®Google Scholar
• Von Bibra H, Thrainsdottir IS, Hansen A, et al. Tissue Doppler imaging for the detection and quantitation of myocardial dysfunction in patients with type 2 diabetes mellitus. Diab Vasc Dis Res. 2005;2(1):24–30.
   PubMedGoogle Scholar
• Jensen MT, Sogaard P, Andersen HU, et al. Prevalence of systolic and diastolic dysfunction in patients with type 1 diabetes without known heart disease: the Thousand & 1 Study. Diabetologia. 2014;57(4):672–680.
   PubMed Web of Science ®Google Scholar
• Fang ZY, Schull-Meade R, Downey M, et al. Determinants of subclinical diabetic heart disease. Diabetologia. 2005;48(2):394–402.
   PubMed Web of Science ®Google Scholar
• Zhu A, Zhang J, Zou T, et al. Associations of blood pressure, glucose or lipids with stroke in different age or gender. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014;39(12):1271–1278.
   PubMedGoogle Scholar
• Yoshino Y, Kumon H, Mori T, et al. Effects of AGXT2 variants on blood pressure and blood sugar among 750 older Japanese subjects recruited by the complete enumeration survey method. BMC Genomics. 2021;22(1):287.
   PubMed Web of Science ®Google Scholar
• Mu Y. Expert consensus on comprehensive management of type 2 diabetes and obesity in China. Chin J Diabet. 2016;10(10):3 (Chinese).
   Google Scholar
• Xin Z, Xueting L, Runtian C, et al. An in-depth analysis of glycosylated haemoglobin level, body mass index and left ventricular diastolic dysfunction in patients with type 2 diabetes. BMC Endocr Disord. 2019;19(1):88.
   PubMed Web of Science ®Google Scholar
• Halpern A, Mancini MC. Diabesity: are weight loss medications effective? Treat Endocrinol. 2005;4(2):65–74.
   PubMedGoogle Scholar
• Jeong-Sook S, Jin HY, Jae-Sik J, et al. The relationships between body mass index and left ventricular diastolic function in a structurally normal heart with normal ejection fraction. J Cardiovasc Ultrasound. 2017;25(1):5–11.
   PubMedGoogle Scholar
• Ng G, Prevedello C, Dolci DY, et al. Impact of diabetes and increasing body mass index category on left ventricular systolic and diastolic function. Am Soc Echocardiogr. 2018;31(8):916–925.
   Google Scholar
• Aljaroudi W, Halley C, Houghtaling P, et al. Impact of body mass index on diastolic function in patients with normal left ventricular ejection fraction. Nutr Diabetes. 2012;2(8):e39.
   PubMedGoogle Scholar
• Wolf P, Winhofer Y, Krssak M, et al. Suppression of plasma free fatty acids reduces myocardial lipid content and systolic function in type 2 diabetes. Nutr Metab Cardiovasc Dis NMCD. 2016;26(5):387–392.
   PubMed Web of Science ®Google Scholar
• Zafrir B, Jain M. Lipid-lowering therapies, glucose control and incident diabetes: evidence, mechanisms and clinical implications. Cardiovasc Drugs Ther. 2014;28(4):361–377.
   PubMed Web of Science ®Google Scholar
• Wang X, Jin S, Hu W. A role of glucose overload in diabetic cardiomyopathy in nonhuman primates. J Diabetes Res. 2021;2021:1–9.
   Web of Science ®Google Scholar
• Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2018;61(1):21–28.
   PubMed Web of Science ®Google Scholar
• Christofides EA, Desai N. Optimal early diagnosis and monitoring of diabetic kidney disease in type 2 diabetes mellitus: addressing the barriers to albuminuria testing. J Prim Care Community Health. 2021;12:215013272110036.
   Web of Science ®Google Scholar
• Jalnapurkar S, Landes S, Wei J, et al. Coronary endothelial dysfunction appears to be a manifestation of a systemic process: a report from the Women’s Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction (WISE-CVD) study. PLoS One. 2021;16(9):e0257184.
   PubMed Web of Science ®Google Scholar
• Chen G, Zhang F, Wang L, et al. Isoflurane alleviates hypoxia/reoxygenation induced myocardial injury by reducing miR-744 mediated SIRT6. Toxicol Mech Methods. 2021;32:235–242.
   PubMed Web of Science ®Google Scholar
• Braile-Sternieri M, Mustafa EM, Ferreira VRR, et al. Main considerations of cardiogenic shock and its predictors: systematic review. Cardiol Res. 2018;9(2):75–82.
   PubMedGoogle Scholar
• San EI. Hyponatremia associated with heart failure: pathological role of Vasopressin-Dependent impaired water excretion. J Clin Med. 2015;4(5):933–947.
   PubMed Web of Science ®Google Scholar
• Ajeeth Fera, Balasubramaniyan, Paari. Hyponatremia and in hospital mortality in acute ST elevation myocardial infarction. J Med Sci Clin Res. 2017;(10).
   Google Scholar
• Tuomilehto S, Irene M, Adler A, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–412.
   PubMedGoogle Scholar